CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq: DYAX) announced today that the United States Patent and Trademark office issued U.S. Patent No. 7,118,879, Dyax’s sixth U.S. patent covering its proprietary phage display technology. This new patent provides Dyax with additional patent claims that cover methods for selecting antibodies physically associated with filamentous phage. In addition to its six U.S. patents, Dyax holds several issued patents for phage display in Canada, Israel, and Japan, with pending applications in other countries.
